Rivaroxaban

Product number: C2138
CAS number: 366789-02-8
Molecular formula: C₁₉H₁₈ClN₃O₅S
Molecular weight: 435,88 g.mol-1
Min. purity: 98,00 %
Solubility: refer to COA

Stability: ≥ 1 year
Shipping: 24/48h for products in stock

Make a request

Product Number: C2138

Size

Qty

Description

Rivaroxaban is intended for Pharmaceuticals applications. It is an orally active, direct inhibitor of Factor Xa and a novel antithrombotic agent. All information about Rivaroxaban is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

References

Rivaroxaban and apixaban in orthopaedics: is there a difference in their plasma concentrations and anticoagulant effects? Blood Coagul Fibrinolysis. 2015 Dec; 26(8): 925–933. [...]
Rivaroxaban Delivery and Reversal at a Venous Flow Rate Arteriosclerosis, Thrombosis, and Vascular Biology. 2012;32:2877–2883 [...]
Efficacy of pro- and anticoagulant strategies in plasma of patients undergoing hepatobiliary surgery J Thromb Haemost. 2020;18:2840–2851 [...]
Invasive Infections with Nannizziopsis obscura Species Complex in 9 Patients from West Africa, France, 2004–20201 Emerg Infect Dis. 2020 Sep; 26(9): 2022–2030 [...]
A UHPLC-MS/MS method to simultaneously quantify apixaban, edoxaban and rivaroxaban in human plasma and breast milk: For emerging lactation studies Journal of Chromatography B Volume 1144, 1 May 2020, 122095 [...]
In vitro assessment of P-gp and BCRP transporter-mediated drug–drug interactions of riociguat with direct oral anticoagulants fundamental & clinical pharmacology, volume 34, issue 1, February 2020, p. 109-119 [...]
Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban European Journal of Pharmaceutics and Biopharmaceutics Volume 148, March 2020, Pages 27-37 [...]
Resolving DOAC interference on antithrombin activity testing on a FXa based method by the use of activated carbon. Clinica Chimica Acta - Volume 538, 1 January 2023, Pages 216-220 [...]